Hypertension and risk of uterine leiomyomata in US black women

Human Reproduction

Volumn 27, Issue 5, 2012, Pages 1504-1509

  Radin, R G ^a   Rosenberg, L ^a   Palmer, J R ^a   Cozier, Y C ^a   Kumanyika, S K ^b   Wise, L A ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

African Americans; Epidemiology; Fibroids; Hypertension; Uterine

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; HYSTERECTOMY; INCIDENCE; MAJOR CLINICAL STUDY; ULTRASOUND; UTERINE LEIOMYOMATA; UTERUS MYOMA; UTERUS SURGERY;

EID: 84860205075     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des046     Document Type: Article

References (32)

1. Arslan AA, Gold LI, Mittal K, Suen T-C, Belitskaya-Levy I, Tang M-S, Toniolo P. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 2005;20: 852-863. (Pubitemid 40667828)
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188: 100-107. (Pubitemid 36135604)
3. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol 2005;161: 628-638. (Pubitemid 40411091)
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S,Wright JT Jr et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 2003;289: 2560-2572. (Pubitemid 37430158)
5. Cozier YC, Palmer JR, Horton NJ, Fredman L, Wise LA, Rosenberg L. Relation between neighborhood median housing value and hypertension risk among black women in the United States. Am J Public Health 2007;97: 718-724. (Pubitemid 47280172)
6. Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, Albanes D, Campbell WS, Franz C, Kahle L et al. The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer Causes Control 1995;6: 3-8.
7. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 2002;186: 409-415. (Pubitemid 34234149)
8. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001; 153: 11-19. (Pubitemid 32041891)
9. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111: 1037-1054. (Pubitemid 36826884)
10. Goldberg JD. The effects of misclassification on the bias in the difference between two proportions and the relative odds in the fourfold table. J Am Stat Assoc 1975;70: 561-567.
11. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons, Inc, 1989.
12. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867. (Pubitemid 46024993)
13. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996;41: 483-490. (Pubitemid 26244348)
14. Loutradis D, Antsaklis A, Creatsas G, Hatzakis A, Kanakas N, Gougoulakis A, Michalas S, Aravantinos D. The validity of gynecological ultrasonography. Gynecol Obstet Invest 1990;29: 47-50. (Pubitemid 20047340)
15. Luoto R, Rutanen EM, Auvinen A. Fibroids and hypertension-a cross-sectional study of women undergoing hysterectomy. J Reprod Med 2001;46: 359-364. (Pubitemid 32428782)
16. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90: 967-973. (Pubitemid 27510139)
17. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986;314: 488-500.
18. Rothman K, Greenland S, Lash T. Validity in Epidemiologic Studies, Modern Epidemiology. New York, NY: Lippincott Williams & Wilkins, 2008, 128-147.
19. Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol 2001;44: 316-326. (Pubitemid 32374433)
20. Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000;108(Suppl 5): 821-827.
21. Silver MA, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich) 2005;7: 664-668.
22. Stewart EA. Uterine fibroids. Lancet 2001;357: 293-298. (Pubitemid 32120866)
23. Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update 1996;2: 295-306. (Pubitemid 26408110)
24. Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol 1998;92: 624-627. (Pubitemid 28449614)
25. Takeda T, Sakata M, Isobe A, Miyake A, Nishimoto F, Ota Y, Kamiura S, Kimura T. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Invest 2008;66: 14-17. (Pubitemid 352009124)
26. Therneau TM. Extending the Cox Model. Proceedings of the First Seattle Symposium in Biostatistics: Survival Analysis. New York, NY: Springer Verlag, 1997.
27. Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, Lux LJ, Lohr KN. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess, 154, AHRQ Pub 07-E011. Rockville, MD: Agency for Healthcare Research and Quality, 2007.
28. Wegienka G, Baird DD, Hertz-Picciotto I, Harlow S. Self-reported heavy bleeding associated with uterine leiomyomata. Obstet Gynecol 2003; 101: 431-437. (Pubitemid 36288480)
29. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, Rosenberg L. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology 2005a;16: 346-354. (Pubitemid 40586710)
30. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol 2005b;105: 563-568. (Pubitemid 40271223)
31. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol 2007;110: 1091-1095. (Pubitemid 350059415)
32. Yakar S, Nunez NP, Pennisi P, Brodt P, Sun H, Fallavollita L, Zhao H, Scavo L, Novosyadlyy R, Kurshan N et al. Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 2006;147: 5826-5834. (Pubitemid 44833499)